BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 16825867)

  • 1. Rapid desensitization for hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid desensitization of hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization.
    Breslow RG; Caiado J; Castells MC
    Ann Allergy Asthma Immunol; 2009 Feb; 102(2):155-60. PubMed ID: 19230468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization for hypersensitivity reactions to medications.
    del Carmen Sancho M; Breslow R; Sloane D; Castells M
    Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century.
    Castells Guitart MC
    J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization regimens for drug allergy: state of the art in the 21st century.
    Liu A; Fanning L; Chong H; Fernandez J; Sloane D; Sancho-Serra M; Castells M
    Clin Exp Allergy; 2011 Dec; 41(12):1679-89. PubMed ID: 21883538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
    Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
    Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity.
    Limsuwan T; Castells MC
    Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2005 Nov; 99(2):393-9. PubMed ID: 16054201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity to antineoplastic agents.
    Castells MC
    Curr Pharm Des; 2008; 14(27):2892-901. PubMed ID: 18991707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
    Gammon D; Bhargava P; McCormick MJ
    Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
    Feldweg AM; Lee CW; Matulonis UA; Castells M
    Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children.
    Hong DI; Dioun AF
    J Allergy Clin Immunol Pract; 2014; 2(1):13-9; quiz 20. PubMed ID: 24565764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy.
    Mezzano V; Giavina-Bianchi P; Picard M; Caiado J; Castells M
    BioDrugs; 2014 Apr; 28(2):133-44. PubMed ID: 23990250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.
    Kuo JC; Hawkins C; Yip D
    Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and preparedness for infusion and hypersensitivity reactions.
    Lenz HJ
    Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
    Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
    J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.